Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Metadata
Title
Prevalence of misregistration between SPECT and CT for attenuation-corrected myocardial perfusion SPECT
Authors
Sibyll Goetze
Richard L. Wahl
Publication date
01-03-2007
Publisher
Springer-Verlag
Published in
Journal of Nuclear Cardiology / Issue 2/2007
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1016/j.nuclcard.2006.12.325

Other articles of this Issue 2/2007

Journal of Nuclear Cardiology 2/2007 Go to the issue

Original Articles

Mortality risk associated with ejection fraction differs across resting nuclear perfusion findings

Editorial

How serious a problem for myocardial perfusion assessment is moderate misregistration between SPECT and CT?

ASNC Policy Statement

Verification of experience in cardiovascular computed tomography

Original Articles

A randomized trial of exercise treadmill ECG versus stress SPECT myocardial perfusion imaging as an initial diagnostic strategy in stable patients with chest pain and suspected CAD: Cost analysis

ASNC Information Statement

Timeliness of reporting results of nuclear cardiology procedures

Editor’s Page

Can we enhance quality in nuclear cardiology?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits